ZIM
VRCA icon

Zacks Investment Management’s Verrica Pharmaceuticals VRCA Stock Holding History

Zacks Investment Management’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-3,604
Closed -$279K – 583
2020
Q3 		$279K Sell
3,604
-129
-3% -$10.6K 0.01% 461
2020
Q2 		$411K Sell
3,733
-80
-2% -$9.25K 0.01% 410
2020
Q1 		$417K Hold
3,813
– – 0.01% 399
2019
Q4 		$606K Buy
+3,813
New +$563K 0.01% 434

Other funds holding VRCA

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.79B AUM 30.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Zacks Investment Management's VRCA Position: Q4 2020 in Review

Zacks Investment Management sold out of Verrica Pharmaceuticals (VRCA) in Q4 2020, closing a stake of 3,604 shares — an estimated $279K sold.

Zacks Investment Management first reported a position in VRCA in Q4 2019 and held it in 4 quarters. The position peaked at $606K in Q4 2019. 44 funds tracked by Wall St. Rank hold VRCA as of Q4 2020.

  • Zacks Investment Management reported no remaining Verrica Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Zacks Investment Management sold 3,604 Verrica Pharmaceuticals shares in Q4 2020, an estimated $279K.
  • Zacks Investment Management first reported a position in Verrica Pharmaceuticals in Q4 2019 and held it in 4 quarters.
  • Zacks Investment Management's Verrica Pharmaceuticals position peaked at $606K in Q4 2019.
  • 44 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q4 2020.

Based on Zacks Investment Management's 13F filing for Q4 2020, filed 16 Feb 2021.